TESTICULAR CANCER TREATMENT
Authors:
prof. MUDr. Dalibor Ondruš, DrSc.
Authors place of work:
I. onkologická klinika LF Univerzity Komenského a Onkologického ústavu sv. Alžbety, Bratislava
Published in the journal:
Urol List 2006; 4(3): 22-26
Summary
The paper discusses radical orchiectomy, or organ sparing surgery in primary treatment of testicular cancer. Detailed histological examination of section tissue is a prerequisite for subsequent therapeutic steps. We assess the therapeutic options in seminomas and non-seminomatous tumors according to the clinical stage of the disease. The paper tackles the role of radiotherapy, retroperitoneal lymph node dissection, front-line chemotherapy, as well as the place of post-chemotherapy surgery and the options of other lines of chemotherapeutic regimens in the treatment algorithm and the prognosis of the illness according to prognostic factors.
KEY WORDS:
testicular tumour, orchiectomy, chemotherapy, radiotherapy, lymph node dissection
Zdroje
1. Weissbach L. Guidelines for the diagnosis and therapy of testicular cancer and new developments. Urol Int 1999; 63(1): 46-56.
2. Heidenreich A, Holtl W, Albrecht W, Pont J, Engelmann UH. Testis-preserving surgery in bilateral testicular germ cell tumours. Br J Urol 1997; 79(2): 253-257.
3. Molnárová A. Úloha rádioterapie v liečbe seminómov. Klin Onkol 1996; 9: 9-10.
4. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Horwich A, Klepp O, Laguna MP, Pizzocaro G. EAU Guidelines on Testicular Cancer. Arnheim: EAU Healthcare Office 2005: 52.
5. Zvara V, Horňák M. Urologické operácie. Martin: Osveta 1983: 224.
6. Peckham MJ, Barrett A, Husband JE, Hendry WF. Orchidectomy alone in testicular stage I nonseminomatous germ cell tumors. Lancet 1982; 2(8300): 678-680.
7. Albers P, Siener R, Kliesch S, Weissbach L, Krege S et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors. Results of the German Testicular Cancer Study Group Trial. J Clin Oncol 2003; 21(8): 1505-1512.
8. Ondruš D. Dlhodobé skúsenosti s diferencovaným liečebným prístupom u pacientov s neseminomatóznym nádorom testis v I. klinickom štádiu. Urológia 2003; 9(3): 20-25.
9. Greist A, Einhorn LH, Williams SD, Donohue JP, Rowland RG. Pathologic findings at orchiectomy following chemotherapy in disseminated testicular cancer. J Clin Oncol 1984; 2(9): 1025-1027.
10. Ondruš D, Horňák M, Breza J, Maoška J, Schnorrer M et al. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer. Int Urol Nephrol 2001; 32(4): 665-667.
11. Einhorn LH, Donohue JP. Cis-diamminedichloroplatinum, vinblastine, bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87(3): 293-298.
12. Peckham MJ, Barrett A, Liew KH, Horwich A, Robinson B et al. The treatment of metastatic germ cell testicular tumours with bleomycin, etoposide and cisplatin (BEP). Br J Cancer 1983; 47(5): 613-619.
13. Abrahámová J. Terapie testikulárních germinálních nádorù. In: Dvoøáček J, Babjuk M (eds). Onkourologie. Praha: Galén 2005: 495-501.
14. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A Prognostic Factor-Based Staging System for Metastatic Germ Cell Cancers. J Clin Oncol 1997; 15(2): 594-603.
15. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 5(9): 1377-1399.
16. Mardiak J, Šálek T, Syčová-Milá Z, Obertová J, Hlavatá Z, Mego M, Rečková M, Koza I. Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. Neoplasma 2005a; 52(6): 497-501.
17. Mardiak J. Liečba pokročilých nádorov z germinatívnych buniek. Via Practica 2005; 2(Suppl 1): 42-45.
18. Reiter WJ, Brodowicz T, Alavi S, Zielinski CC, Kozak W, Maier U, Nost G, Lipsky H, Marberger M, Kratzik C. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma. J Clin Oncol 2001; 19(1): 101-104.
19. Motzer RJ, Boston B, Carducci MA, Fishman M, Hancock SL et al. Clinical Practice Guidelines in Oncology. Testicular Cancer, version 1.2006. National Comprehensive Cancer Network 2005: 35.
20. Horňák M, Maťoška J. Nádory testis, diagnostika a liečba. Bratislava: Veda 1990: 260.
21. Chung PW, Jewett MA, Warde PR. Testicular radiation for primary seminoma in a solitary testis. Can J Urol 2006; 13(1): 2975-2977.
22. Mardiak J, Šálek T, Syčová-Milá Z, Obertová J, Hlavatá Z, Mego M, Rečková M, Koza I. Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study. Neoplasma 2005b; 52(3): 243-247.
Štítky
Paediatric urologist UrologyČlánok vyšiel v časopise
Urological Journal
2006 Číslo 3
Najčítanejšie v tomto čísle
- LYMPHATIC DRAINAGE OF THE TESTES
- TESTICULAR TERATOMA - CURRENT CLASSIFICATION ACCORDING TO WHO 2004
- PENILE PROSTHESIS IN THE THIRD MILLENNIUM
- LARGE CELL CALCIFYING SERTOLI CELL TUMOR-REVIEW